Travere Therapeutics, Inc. · NASDAQ:TVTX
Reed Elizabeth E sold 24,250 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 6, 2026 · Filed May 6, 2026
From May 4 to May 6, 2026, Reed Elizabeth E (Chief Legal Officer and GC) sold 24,250 Travere Therapeutics, Inc. shares at an average US$45.06 for US$1.09M under a trading plan, leaving 105,211 shares. Filed May 6, 2026 (Form 4).
- Sold
- 24,250 shares
- Price
- US$45.06 average (US$43.95 to US$46.65)
- Value
- US$1.09M
- Holding after
- 105,211 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer and GC
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 20,000 | US$17.96 | 125,211 | Direct |
| May 4, 2026 | Common Stock | Sale | 20,000 | US$45.00 | 105,211 | Direct |
| May 4, 2026 | Common Stock | Option exercise | 4,250 | 109,461 | Direct | |
| May 5, 2026 | Common Stock | Sale | 2,174 | US$46.65 | 107,287 | Direct |
| May 6, 2026 | Common Stock | Sale | 2,076 | US$43.95 | 105,211 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Reed Elizabeth E
- Travere Therapeutics, Inc. shareholders
- Form 4 · Reed Elizabeth E · Sep 17, 2026
- Form 4 · Reed Elizabeth E · Apr 15, 2026
- Form 4 · Reed Elizabeth E · Apr 2, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026